162 related articles for article (PubMed ID: 7753862)
1. Characterization of the stable L-arginine-derived relaxing factor released from cytokine-stimulated vascular smooth muscle cells as an NG-hydroxyl-L-arginine-nitric oxide adduct.
Hecker M; Boese M; Schini-Kerth VB; Mülsch A; Busse R
Proc Natl Acad Sci U S A; 1995 May; 92(10):4671-5. PubMed ID: 7753862
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide and another potent vasodilator are formed from NG-hydroxy-L-arginine by cultured endothelial cells.
Zembowicz A; Hecker M; Macarthur H; Sessa WC; Vane JR
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11172-6. PubMed ID: 1662386
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.
Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Vane JR
Br J Pharmacol; 1992 Dec; 107(4):1001-7. PubMed ID: 1281716
[TBL] [Abstract][Full Text] [Related]
4. NG-hydroxy-L-arginine and hydroxyguanidine potentiate the biological activity of endothelium-derived relaxing factor released from the rabbit aorta.
Zembowicz A; Chłopicki S; Radziszewski W; Vane JR; Gryglewski RJ
Biochem Biophys Res Commun; 1992 Dec; 189(2):711-6. PubMed ID: 1472042
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 beta induces the production of an L-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta.
Schini VB; Junquero DC; Scott-Burden T; Vanhoutte PM
Biochem Biophys Res Commun; 1991 Apr; 176(1):114-21. PubMed ID: 1708241
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1beta-induced, nitric oxide-dependent and -independent inhibition of vascular smooth muscle contraction.
Takizawa S; Ozaki H; Karaki H
Eur J Pharmacol; 1997 Jul; 330(2-3):143-50. PubMed ID: 9253947
[TBL] [Abstract][Full Text] [Related]
7. Smooth muscle relaxing effects of NO, nitrosothiols and a nerve-induced relaxing factor released in guinea-pig colon.
Iversen HH; Gustafsson LE; Leone AM; Wiklund NP
Br J Pharmacol; 1994 Dec; 113(4):1088-92. PubMed ID: 7889258
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of the endothelium-dependent relaxation induced by NG-hydroxy-L-arginine.
Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Gryglewski RJ; Vane JR
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S57-9. PubMed ID: 1282987
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine.
Hecker M; Mitchell JA; Harris HJ; Katsura M; Thiemermann C; Vane JR
Biochem Biophys Res Commun; 1990 Mar; 167(3):1037-43. PubMed ID: 2322257
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cytokine-induced nitric oxide production by transforming growth factor-beta 1 in human smooth muscle cells.
Junquero DC; Scott-Burden T; Schini VB; Vanhoutte PM
J Physiol; 1992 Aug; 454():451-65. PubMed ID: 1282159
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-derived nitric oxide relaxes nonvascular smooth muscle.
Buga GM; Gold ME; Wood KS; Chaudhuri G; Ignarro LJ
Eur J Pharmacol; 1989 Feb; 161(1):61-72. PubMed ID: 2542037
[TBL] [Abstract][Full Text] [Related]
12. Vascular myocyte-derived nitric oxide is an autocrine that limits vasoconstriction.
Charpie JR; Webb RC
Biochem Biophys Res Commun; 1993 Jul; 194(2):763-8. PubMed ID: 8343158
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of vascular actions of the nitric oxide-trapping agent, N-methyl-D-glucamine dithiocarbamate-Fe2+, on basal and agonist-stimulated nitric oxide activity.
Pieper GM; Lai CS
Biochem Biophys Res Commun; 1996 Feb; 219(2):584-90. PubMed ID: 8605031
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-derived relaxing factor (EDRF). Production from L-arginine.
Johns RA; Rengasamy A
Adv Exp Med Biol; 1991; 301():215-27. PubMed ID: 1662463
[No Abstract] [Full Text] [Related]
15. Similarity between the vasorelaxing activity of dinitrosyl iron cysteine complexes and endothelium-derived relaxing factor.
Vedernikov YP; Mordvintcev PI; Malenkova IV; Vanin AF
Eur J Pharmacol; 1992 Feb; 211(3):313-7. PubMed ID: 1618273
[TBL] [Abstract][Full Text] [Related]
16. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo.
Moncada S; Rees DD; Schulz R; Palmer RM
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2166-70. PubMed ID: 1848694
[TBL] [Abstract][Full Text] [Related]
17. Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells.
Durante W; Schini VB; Scott-Burden T; Junquero DC; Kroll MH; Vanhoutte PM; Schafer AI
Am J Physiol; 1991 Dec; 261(6 Pt 2):H2024-30. PubMed ID: 1661096
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 impairs both vascular contraction and relaxation in rabbit isolated aorta.
Robert R; Chapelain B; Jean T; Néliat G
Biochem Biophys Res Commun; 1992 Jan; 182(2):733-9. PubMed ID: 1734880
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide synthase inhibitors inhibit interleukin-1 beta-induced depression of vascular smooth muscle.
French JF; Lambert LE; Dage RC
J Pharmacol Exp Ther; 1991 Oct; 259(1):260-4. PubMed ID: 1717680
[TBL] [Abstract][Full Text] [Related]
20. DL-propranolol augments production of NO induced by cytokines in cultured aortic smooth muscle of the rat.
De Castro M; Mota-Filipe H; Caneira M; Rico JM; Scott-Burden T; Vanhoutte PM
Eur J Pharmacol; 1994 Aug; 261(1-2):199-203. PubMed ID: 8001644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
